| | |
|
37 Capital CLO 1 Ltd., 6.79%, 10/15/34 (Call 07/15/24), (3-mo. CME Term SOFR + 1.462%)(a)(b) | | |
37 Capital CLO II, 7.33%, 07/15/34 (Call 07/15/24), (3-mo. CME Term SOFR + 2.000%)(a)(b) | | |
522 Funding CLO Ltd., 6.66%, 04/15/35 (Call 07/15/24), (3-mo. CME Term SOFR + 1.330%)(a)(b) | | |
720 East CLO IV Ltd., 6.89%, 04/15/37 (Call 04/15/26), (3-mo. CME Term SOFR + 1.600%)(a)(b) | | |
AB BSL CLO 4 Ltd., 7.82%, 04/20/36 (Call 04/20/25), (3-mo. CME Term SOFR + 2.500%)(a)(b) | | |
AGL CLO 12 Ltd., 6.75%, 07/20/34 (Call 07/20/24), (3-mo. CME Term SOFR + 1.422%)(a)(b) | | |
AGL CLO 5 Ltd. Series 2020 5A, Class A1R, 6.75%, 07/20/34 (Call 07/20/24), (3 mo. LIBOR US + 1.160%)(a)(b) | | |
AGL CLO 7 Ltd., 6.79%, 07/15/34 (Call 07/15/24), (3-mo. SOFR + 1.461%)(a)(b) | | |
Aimco CLO 11 Ltd., 6.71%, 10/17/34 (Call 07/17/24), (3-mo. LIBOR US + 1.130%)(a)(b) | | |
Aimco CLO 20 Ltd., 7.56%, 10/16/36 (Call 10/16/25), (3-mo. CME Term SOFR + 2.200%)(a)(b) | | |
Apidos CLO XXXII, 6.91%, 01/20/33 (Call 07/20/24), (3-mo. CME Term SOFR + 1.582%)(a)(b) | | |
Apidos CLO XXXIII Series 2020 33A, Class AR, 6.73%, 10/24/34 (Call 07/24/24), (3-mo. SOFR +1.411%)(a)(b) | | |
Apidos CLO XXXIV, 6.74%, 01/20/35 (Call 07/20/24), (3-mo. CME Term SOFR + 1.412%)(a)(b) | | |
Apidos CLO XXXVII, 6.72%, 10/22/34 (Call 07/22/24), (3-mo. CME Term SOFR + 1.392%)(a)(b) | | |
Ares Loan Funding IV Ltd., 7.08%, 10/15/36 (Call 10/15/25), (3-mo. CME Term SOFR + 1.750%)(a)(b) | | |
Ares LVI CLO Ltd., 6.75%, 10/25/34 (Call 07/25/24), (3-mo. CME Term SOFR + 1.422%)(a)(b) | | |
Bain Capital Credit CLO Ltd., 7.12%, 07/24/36 (Call 10/24/25), (3-mo. CME Term SOFR + 1.800%)(a)(b) | | |
Ballyrock CLO 14 Ltd., 7.29%, 01/20/34 (Call 07/20/24), (3-mo. CME Term SOFR + 1.962%)(a)(b) | | |
Ballyrock CLO 16 Ltd., 6.72%, 07/20/34 (Call 07/20/24), (3-mo. SOFR +1.391%)(a)(b) | | |
Ballyrock CLO 19 Ltd., 6.65%, 04/20/35 (Call 07/20/24), (3-mo. SOFR + 1.330%)(a)(b) | | |
| | |
7.30%, 04/25/36 (Call 04/25/25), (3-mo. CME Term SOFR + 1.980%)(a)(b) | | |
8.52%, 04/25/36 (Call 04/25/25), (3-mo. CME Term SOFR + 3.200%)(a)(b) | | |
Battery Park CLO II Ltd., 7.53%, 10/20/35 (Call 10/20/24), (3-mo. CME Term SOFR + 2.210%)(a)(b) | | |
Beechwood Park CLO Ltd., 6.62%, 01/17/35 (Call 07/17/24), (3-mo. CME Term SOFR + 1.300%)(a)(b) | | |
Benefit Street Partners CLO XVII Ltd. Series 2019 17A, Class AR, 6.67%, 07/15/32 (Call 07/15/24), (3 mo. LIBOR US + 1.080%)(a)(b) | | |